MedKoo Cat#: 414340 | Name: Nesapidil

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Nesapidil is a vasodilatory antihypertensive agent primarily acting through α1-adrenergic receptor antagonism and calcium channel blocking activity. Preclinical studies have demonstrated that nesapidil inhibits phenylephrine-induced contractions in isolated rat aortic rings with an IC₅₀ in the low micromolar range, indicative of its α1-adrenoceptor antagonistic effect. Additionally, it reduces calcium-induced contractions in depolarized vascular smooth muscle preparations, supporting its calcium channel blocking properties. In vivo, nesapidil significantly lowers systolic and diastolic blood pressure in spontaneously hypertensive rats (SHRs) in a dose-dependent manner, with effective oral doses ranging from 1 to 10 mg/kg. Its dual mechanism of action makes it a candidate for managing hypertension, although clinical development remains limited.

Chemical Structure

Nesapidil
Nesapidil
CAS#90326-85-5

Theoretical Analysis

MedKoo Cat#: 414340

Name: Nesapidil

CAS#: 90326-85-5

Chemical Formula: C23H28N4O4

Exact Mass: 424.2111

Molecular Weight: 424.50

Elemental Analysis: C, 65.08; H, 6.65; N, 13.20; O, 15.08

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
118778-75-9
Synonym
Nesapidil
IUPAC/Chemical Name
(+-)-1-(4-(o-Methoxyphenyl)-1-piperazinyl)-3-(m-(5-methyl-1,3,4-oxadiazol-2-yl)phenoxy)-2-propanol
InChi Key
FYKZHAJQLBLBJO-UHFFFAOYSA-N
InChi Code
InChI=1S/C23H28N4O4/c1-17-24-25-23(31-17)18-6-5-7-20(14-18)30-16-19(28)15-26-10-12-27(13-11-26)21-8-3-4-9-22(21)29-2/h3-9,14,19,28H,10-13,15-16H2,1-2H3
SMILES Code
OC(COC1=CC=CC(C2=NN=C(C)O2)=C1)CN3CCN(C4=CC=CC=C4OC)CC3
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
To be determined
Shelf Life
>2 years if stored properly
Drug Formulation
To be determined
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 424.50 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Siwach A, Verma PK. Therapeutic potential of oxadiazole or furadiazole containing compounds. BMC Chem. 2020 Dec 7;14(1):70. doi: 10.1186/s13065-020-00721-2. PMID: 33372629; PMCID: PMC7722446. 2: Ahsan MJ. 1,3,4-Oxadiazole Containing Compounds As Therapeutic Targets For Cancer Therapy. Mini Rev Med Chem. 2021 Feb 26. doi: 10.2174/1389557521666210226145837. Epub ahead of print. PMID: 33634756.